Table 3.
Variable | Model 1 | Model 2 | Model 3 | Model 4 | Model 5a |
---|---|---|---|---|---|
Unadjusted | Race, Age, and Sex | Race, Age, Sex, DM, Kidney Disease, and PAD Severity | Race, Age, Sex, DM, Kidney Disease, PAD Severity, and SES | Fully Adjusted Model | |
Race | |||||
White | Ref. | Ref. | Ref. | Ref. | Ref. |
Black | 2.08 (1.98–2.19) | 2.02 (1.93–2.12) | 1.56 (1.49–1.64) | 1.53 (1.45–1.60) | 1.37 (1.30–1.45) |
Ageb | ··· | 0.99 (0.98–0.99) | 0.99 (0.99–0.99) | 0.99 (0.98–0.99) | 0.99–0.98–0.99) |
Sex | |||||
Male | ··· | Ref. | Ref. | Ref. | Ref. |
Female | ··· | 0.39 (0.31–0.49) | 0.46 (0.37–0.57) | 0.46 (0.36–0.57) | 0.46 (0.37–0.57) |
DM | ··· | ··· | 1.71 (1.63–1.79) | 1.72 (1.64–1.80) | 1.64 (1.49–1.82) |
CKD or ESRD | ··· | ··· | 2.02 (1.89–2.15) | 2.03 (1.90–2.16) | 1.59 (1.46–1.73) |
PAD severity | |||||
Claudication | ··· | ··· | Ref. | Ref. | Ref. |
Unspecifiedc | ··· | ··· | 0.88 (0.81–0.96 | 0.88 (0.81–0.96) | 0.88 (0.80–0.96) |
CLI | ··· | ··· | 7.76 (7.72–8.41) | 7.74 (7.14–8.39) | 6.43 (5.92–6.98) |
SES: median income (household) of residential ZCTA | |||||
>$40 001 | ··· | ··· | ··· | Ref. | Ref. |
≤$40 000 | ··· | ··· | ··· | 1.12 (1.07–1.17) | 1.12 (1.06–1.17) |
Data are shown as hazard ratio (95% confidence interval). CKD indicates chronic kidney disease; CLI, critical limb ischemia; DM, diabetes mellitus; ESRD, end‐stage renal disease; PAD, peripheral artery disease; Ref., referent; SES, socioeconomic status; ZCTA, ZIP code tabulation area.
Fully adjusted model also adjusted for comorbidities including hypertension, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, atrial fibrillation, carotid disease, depression, body mass index, urban/rural population mix, smoking, creatinine level, and medication use (statins, antiplatelet agents, cilostazol, and antiglycemics [insulin/oral]).
One‐year increase.
Per International Classification of Diseases, Ninth Revision codes.